BackMEI Pharma Overview

MEI Pharma Receivables

Track MEI Pharma's receivables ($7.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$7.90M

Peer average

Loading

MEI Pharma Receivables History

Loading

MEI Pharma vs. peers: Receivables Comparison

Loading

MEI Pharma Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

MEI Pharma (MEIP) FAQ

MEI Pharma (MEIP) currently reports a receivables of $7.9M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore MEI Pharma's receivables history and peer comparisons.

MEI Pharma's receivables changed from $0 to $7.9M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

MEI Pharma reported $7.9M in receivables as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $7.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for MEI Pharma, and consider following MEIP for alerts when major investors trade the stock.

MEI Pharma is classified in the Healthcare sector. On receivables, it currently shows $7.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MEIP with unrelated industries.